Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy

Accumulating evidence demonstrates the decisive role of the gut microbiota in determining the effectiveness of anticancer therapeutics such as immunogenic chemotherapy or immune checkpoint blockade in preclinical tumor models, as well as in cancer patients. In synthesis, it appears that a normal int...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncoimmunology
Hlavní autoři: Daillère, Romain, Derosa, Lisa, Bonvalet, Mélodie, Segata, Nicola, Routy, Bertrand, Gariboldi, Manuela, Budinská, Eva, De Vries, I. Jolanda M., Naccarati, Alessio Gordon, Zitvogel, Valérie, Caldas, Carlos, Engstrand, Lars, Loilbl, Sibylle, Fieschi, Jacques, Heinzerling, Lucie, Kroemer, Guido, Zitvogel, Laurence
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2020
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7466862/
https://ncbi.nlm.nih.gov/pubmed/32934879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1774298
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky